Dimensional Fund Advisors LP Raises Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Dimensional Fund Advisors LP raised its holdings in ICU Medical, Inc. (NASDAQ:ICUIFree Report) by 4.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 220,624 shares of the medical instruments supplier’s stock after purchasing an additional 9,196 shares during the quarter. Dimensional Fund Advisors LP owned 0.91% of ICU Medical worth $22,005,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of ICUI. Jump Financial LLC acquired a new position in shares of ICU Medical in the 4th quarter worth approximately $352,000. Charles Schwab Investment Management Inc. boosted its position in shares of ICU Medical by 14.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 192,773 shares of the medical instruments supplier’s stock worth $19,227,000 after buying an additional 23,816 shares during the period. Maryland State Retirement & Pension System acquired a new stake in shares of ICU Medical in the fourth quarter valued at $890,000. M&T Bank Corp raised its holdings in shares of ICU Medical by 5.9% in the 4th quarter. M&T Bank Corp now owns 4,938 shares of the medical instruments supplier’s stock valued at $493,000 after buying an additional 277 shares during the period. Finally, State of New Jersey Common Pension Fund D lifted its stake in ICU Medical by 74.9% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 29,573 shares of the medical instruments supplier’s stock worth $2,950,000 after acquiring an additional 12,660 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Stock Down 2.6 %

Shares of NASDAQ ICUI opened at $107.66 on Wednesday. The stock has a market cap of $2.62 billion, a P/E ratio of -43.94 and a beta of 0.73. The business’s fifty day simple moving average is $101.83 and its 200-day simple moving average is $98.58. ICU Medical, Inc. has a 12-month low of $78.28 and a 12-month high of $196.57. The company has a current ratio of 2.61, a quick ratio of 1.09 and a debt-to-equity ratio of 0.76.

ICU Medical (NASDAQ:ICUIGet Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.06. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. The company had revenue of $566.66 million for the quarter, compared to analyst estimates of $553.15 million. As a group, equities analysts predict that ICU Medical, Inc. will post 3.5 EPS for the current fiscal year.

Insider Activity at ICU Medical

In other ICU Medical news, Director George A. Lopez sold 1,890 shares of the stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $104.22, for a total value of $196,975.80. Following the sale, the director now directly owns 317,753 shares of the company’s stock, valued at approximately $33,116,217.66. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, COO Christian B. Voigtlander sold 12,539 shares of the company’s stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $103.95, for a total value of $1,303,429.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director George A. Lopez sold 1,890 shares of the stock in a transaction on Monday, March 11th. The shares were sold at an average price of $104.22, for a total transaction of $196,975.80. Following the completion of the transaction, the director now directly owns 317,753 shares in the company, valued at $33,116,217.66. The disclosure for this sale can be found here. Insiders have sold a total of 25,498 shares of company stock valued at $2,633,440 over the last 90 days. 6.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Separately, KeyCorp lifted their target price on ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research report on Wednesday, February 28th.

Read Our Latest Stock Analysis on ICUI

About ICU Medical

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Read More

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIFree Report).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.